Sodium borohydride → HCID 131727373, compound

HRID 1788035Notes

Reaction equation

HRID 1788035 reaction equation
[S:1]([O:8][C:9]1[C:13]2[N:14]=[C:15]([N:22]3[CH2:27][CH2:26][N:25]([C:28]4[CH:33]=[CH:32][C:31]([Cl:34])=[CH:30][CH:29]=4)[CH2:24][CH2:23]3)[N:16]=[C:17]([NH:18][CH2:19][CH2:20][CH3:21])[C:12]=2[S:11][CH:10]=1)([C:4]([F:7])([F:6])[F:5])(=[O:3])=[O:2].[BH4-].[Na+]>CO>[S:1]([O:8][CH:9]1[C:13]2[N:14]=[C:15]([N:22]3[CH2:27][CH2:26][N:25]([C:28]4[CH:29]=[CH:30][C:31]([Cl:34])=[CH:32][CH:33]=4)[CH2:24][CH2:23]3)[N:16]=[C:17]([NH:18][CH2:19][CH2:20][CH3:21])[C:12]=2[S:11][CH2:10]1)([C:4]([F:6])([F:5])[F:7])(=[O:3])=[O:2]

Participants

4

Procedure

0.050 g (0.12 mmol) of 2-[4-(4-chlorophenyl)piperazin-1-yl]-4-propylaminothieno[3,2-d]pyrimidin-7-ol triflate (IX) is dissolved in 1 mL of methanol and 0.020 g (0.53 mmol) of sodium borohydride is added. The reaction mixture is stirred for 16 hours at ambient temperature, then concentrated by evaporation. The residue is purified by chromatography using HPLC through an RP column (column: Microsorb, RP-C18). Corresponding fractions are combined and lyophilized. 0.013 g of product X (20%) is obtained as a powder. 1H NMR (400 MHz, DMSO): 7.26 (2H, d); 7.00 (2H, d); 5.15-5.09 (1H, m); 3.86-3.79 (4H, m), 3.63-3.55 (2H, m); 3.42-3.33 (2H, m); 3.28-3.22 (4H, m); 3.18-3.11 (1H, m); 1.63-1.52 (2H, m); 0.88 (3H, t).

Workup

  1. concentrationconcentrated by evaporation
  2. customThe residue is purified by chromatography

Sources & evidence

ORD record
ord-96c7d4d75bf445ef8e08b6b3aec22c59
Source dataset
uspto-grants-2009_03
Patent number
US07511045B2

Reaction notes

Loading…